Seda Erişen Karaca
Research Subjects
Seda Erişen Karaca has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Elif Özsu
Department of Pediatric Endocrinology, School of Medicine, Ankara University, Ankara, Turkey
4 shared publications - Gizem Şenyazar
Department of Pediatric Endocrinology , 63990 Ankara University Faculty of Medicine , Ankara , Türkiye
4 shared publications - Merih Berberoğlu
Department of Pediatric Endocrinology, School of Medicine, Ankara University, Ankara, Turkey
4 shared publications - Sirmen Kızılcan Çetin
Department of Pediatric Endocrinology, Ankara Bilkent City Hospital, Ankara, Turkey
4 shared publications - Zehra Aycan
Ankara University
4 shared publications - Zeynep Şıklar
Division of Pediatric Endocrinology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Turkey
4 shared publications
Latest Publications
- 30 June 2026
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 79 (2) , 142-149
Clinical Evaluation And Treatment Outcomes In Non-Congenital Adrenal Hyperplasia: Insights From Primary And Central Adrenal Insufficiency Patients
Introduction: Adrenal insufficiency is a life-threatening endocrine disorder resulting from impaired cortisol production. It develops due to dysfunction of either the adrenal glands or the hypothalamic–pituitary axis. In children, the etiology and clinical manifestations vary widely, and delays in diagnosis and treatment can lead to significant morbidity. Objective: This study aimed to evaluate the clinical characteristics, etiological distribution, and treatment management of children diagnosed with primary adrenal insufficiency (PAI) and central adrenal insufficiency (CAI), excluding those with congenital adrenal hyperplasia (CAH). Methods: A retrospective analysis was conducted on 56 patients aged 0–18 years with PAI and CAI, followed by our Pediatric Endocrinology Department. Patients with CAH, secondary adrenal insufficiency due to steroid use, adrenal insufficiency from trauma, infections, or incomplete data were excluded. Data on clinical presentation, laboratory results, genetic assessments, and treatment were evaluated. Results: Of the 56 patients (28 males, 28 females), 75% (n=42) had CAI, and 25% (n=14) had PAI. Common etiologies in CAI included craniopharyngioma (n=21), while ACTH resistance (n=6) and APECED (n=5) were prevalent in PAI. The mean age at presentation was 6.99 ± 5.81 years, with PAI patients presenting at a younger median age (3.46 years) compared to CAI patients (6.83 years, p=0.11). Due to the predominance of craniopharyngioma patients, CAI patients had shorter stature (-1.03 ± 1.3 SD, p=0.01) and higher BMI SD scores (0.86 ± 1.72, p=0.007) than PAI patients. PAI patients exhibited higher baseline cortisol levels (7.22 ± 4.73 mcg/dL, p=0.01) and required higher initial hydrocortisone doses (20.88 ± 22.6 mg/m²/day) than CAI patients (11.49 ± 3.79 mg/m²/day, p=0.002). Conclusion: PAI patients presented younger and required higher hydrocortisone doses than CAI patients despite having higher baseline cortisol levels. Fatigue and hypoglycemia were frequent symptoms in PAI, while CAI presentations varied based on etiology.
- 30 June 2026
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 79 (2) , 142-149
Clinical Evaluation And Treatment Outcomes In Non-Congenital Adrenal Hyperplasia: Insights From Primary And Central Adrenal Insufficiency Patients
Introduction: Adrenal insufficiency is a life-threatening endocrine disorder resulting from impaired cortisol production. It develops due to dysfunction of either the adrenal glands or the hypothalamic–pituitary axis. In children, the etiology and clinical manifestations vary widely, and delays in diagnosis and treatment can lead to significant morbidity. Objective: This study aimed to evaluate the clinical characteristics, etiological distribution, and treatment management of children diagnosed with primary adrenal insufficiency (PAI) and central adrenal insufficiency (CAI), excluding those with congenital adrenal hyperplasia (CAH). Methods: A retrospective analysis was conducted on 56 patients aged 0–18 years with PAI and CAI, followed by our Pediatric Endocrinology Department. Patients with CAH, secondary adrenal insufficiency due to steroid use, adrenal insufficiency from trauma, infections, or incomplete data were excluded. Data on clinical presentation, laboratory results, genetic assessments, and treatment were evaluated. Results: Of the 56 patients (28 males, 28 females), 75% (n=42) had CAI, and 25% (n=14) had PAI. Common etiologies in CAI included craniopharyngioma (n=21), while ACTH resistance (n=6) and APECED (n=5) were prevalent in PAI. The mean age at presentation was 6.99 ± 5.81 years, with PAI patients presenting at a younger median age (3.46 years) compared to CAI patients (6.83 years, p=0.11). Due to the predominance of craniopharyngioma patients, CAI patients had shorter stature (-1.03 ± 1.3 SD, p=0.01) and higher BMI SD scores (0.86 ± 1.72, p=0.007) than PAI patients. PAI patients exhibited higher baseline cortisol levels (7.22 ± 4.73 mcg/dL, p=0.01) and required higher initial hydrocortisone doses (20.88 ± 22.6 mg/m²/day) than CAI patients (11.49 ± 3.79 mg/m²/day, p=0.002). Conclusion: PAI patients presented younger and required higher hydrocortisone doses than CAI patients despite having higher baseline cortisol levels. Fatigue and hypoglycemia were frequent symptoms in PAI, while CAI presentations varied based on etiology.
- Open Access
- 11 November 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (1) , 10-15
Pubertal characteristics, final height, and associated factors in patients with nonclassical congenital adrenal hyperplasia: a single center experience
Objectives: Nonclassical congenital adrenal hyperplasia (NCCAH) is a mild form of 21-hydroxylase deficiency that can lead to premature pubarche, rapid growth, and reduced final height. However, data on pubertal progression and final height outcomes remain variable. Methods: This retrospective study evaluated 27 patients (20 females, seven males) with genetically confirmed NCCAH, followed until final adult height at a single tertiary center between 2000 and 2020. Clinical, hormonal, and genetic parameters were assessed. Patients were grouped according to CYP21A2 mutation status: Group 1 consisted of patients with the c.844G>T (p.Val282Leu) homozygous mutation, Group 2 consisted of patients with the c.844G>T (p.Val282Leu) compound heterozygous mutation, and Group 3 consisted of patients with other mutations. Final height outcomes and pubertal characteristics were analyzed, and predictors of growth and factors affecting pubertal onset were examined using linear regression. Results: The mean age at diagnosis was 8.8 ± 3.2 years. Central precocious puberty (CPP) and rapidly progressive puberty were observed in a total of 9 cases (at presentation and during follow-up). Seven cases used GnRH analogs. Mean final adult height (FAH) SDS was −0.33 ± 0.98, with no significant differences across mutation groups. Pubertal height SDS and height SDS at diagnosis were strongly correlated with FAH SDS (p=0.0001 and p=0.0009, respectively). Although the mean pubertal onset age did not differ significantly across genotypes, menarche was significantly later in the compound heterozygous group (p=0.006). No significant relationship was found between BA/CA, mutation group, and early puberty with either FAH SDS or FAH-predicted adult height (PAH) SDS. Conclusions: Final height in NCCAH is primarily influenced by height at diagnosis, pubertal height SDS, and pubertal growth dynamics, rather than genotype or age at presentation. Regular auxological monitoring, timely recognition of pubertal changes, and individualized treatment decisions are critical for optimizing adult height outcomes.
- 11 November 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (1) , 10-15
Open AccessPubertal characteristics, final height, and associated factors in patients with nonclassical congenital adrenal hyperplasia: a single center experience
Objectives: Nonclassical congenital adrenal hyperplasia (NCCAH) is a mild form of 21-hydroxylase deficiency that can lead to premature pubarche, rapid growth, and reduced final height. However, data on pubertal progression and final height outcomes remain variable. Methods: This retrospective study evaluated 27 patients (20 females, seven males) with genetically confirmed NCCAH, followed until final adult height at a single tertiary center between 2000 and 2020. Clinical, hormonal, and genetic parameters were assessed. Patients were grouped according to CYP21A2 mutation status: Group 1 consisted of patients with the c.844G>T (p.Val282Leu) homozygous mutation, Group 2 consisted of patients with the c.844G>T (p.Val282Leu) compound heterozygous mutation, and Group 3 consisted of patients with other mutations. Final height outcomes and pubertal characteristics were analyzed, and predictors of growth and factors affecting pubertal onset were examined using linear regression. Results: The mean age at diagnosis was 8.8 ± 3.2 years. Central precocious puberty (CPP) and rapidly progressive puberty were observed in a total of 9 cases (at presentation and during follow-up). Seven cases used GnRH analogs. Mean final adult height (FAH) SDS was −0.33 ± 0.98, with no significant differences across mutation groups. Pubertal height SDS and height SDS at diagnosis were strongly correlated with FAH SDS (p=0.0001 and p=0.0009, respectively). Although the mean pubertal onset age did not differ significantly across genotypes, menarche was significantly later in the compound heterozygous group (p=0.006). No significant relationship was found between BA/CA, mutation group, and early puberty with either FAH SDS or FAH-predicted adult height (PAH) SDS. Conclusions: Final height in NCCAH is primarily influenced by height at diagnosis, pubertal height SDS, and pubertal growth dynamics, rather than genotype or age at presentation. Regular auxological monitoring, timely recognition of pubertal changes, and individualized treatment decisions are critical for optimizing adult height outcomes.
- 29 October 2024
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 16 (3) , 249-256
The Effect of COVID-19 Pandemic on Quality of Life in Children with Type 1 Diabetes Mellitus and Their Families Using Insulin Infusion Pumps
Objective: This study aimed to assess the impact of the coronavirus disease (COVID-19) pandemic on the quality of life (QOL) of children with type 1 Diabetes Mellitus (T1DM) and their families, specifically focusing on the effects of insulin infusion pumps. We also aimed to identify changes in both children's and parents' QOL during the pandemic period. Methods: This study utilized the KINDL (KINDer Lebensqualitätsfragebogen: Children’s QOL) questionnaire for the children, and the World Health Organization Quality of Life (WHOQOL)-BREF Turkish Version (TR) (WHO-QOL-BREF-TR) scale for their parents. Data were collected using Google Forms, with assessments performed before and during the pandemic. Results: The study included 61 participants, 38 of whom were female (62.3%), with a mean age of 12.7±2.9 years and a mean diabetes duration of 6.4±2.5 years. Pre-pandemic KINDL scores for "emotional health" and "school" were significantly higher than those during the pandemic (p=0.022 and p=0.002, respectively). Surprisingly, HbA1c levels improved during the pandemic compared to the pre-pandemic values (p
- 29 October 2024
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 16 (3) , 249-256
The Effect of COVID-19 Pandemic on Quality of Life in Children with Type 1 Diabetes Mellitus and Their Families Using Insulin Infusion Pumps
Objective: This study aimed to assess the impact of the coronavirus disease (COVID-19) pandemic on the quality of life (QOL) of children with type 1 Diabetes Mellitus (T1DM) and their families, specifically focusing on the effects of insulin infusion pumps. We also aimed to identify changes in both children's and parents' QOL during the pandemic period. Methods: This study utilized the KINDL (KINDer Lebensqualitätsfragebogen: Children’s QOL) questionnaire for the children, and the World Health Organization Quality of Life (WHOQOL)-BREF Turkish Version (TR) (WHO-QOL-BREF-TR) scale for their parents. Data were collected using Google Forms, with assessments performed before and during the pandemic. Results: The study included 61 participants, 38 of whom were female (62.3%), with a mean age of 12.7±2.9 years and a mean diabetes duration of 6.4±2.5 years. Pre-pandemic KINDL scores for "emotional health" and "school" were significantly higher than those during the pandemic (p=0.022 and p=0.002, respectively). Surprisingly, HbA1c levels improved during the pandemic compared to the pre-pandemic values (p
- Open Access
- 2 July 2024
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 16 (4) , 466-474
Assessment of the Admission and Follow-up Characteristics of Children Diagnosed with Secondary Osteoporosis
Objective: Secondary osteoporosis is a condition when the underlying disease or its treatment causes the bone mass to decrease and the bone structure to deteriorate, increasing the risk of fracture. The importance of diagnosis and treatment during childhood and adolescence is due to the long-term negative effects. In this study, our objectives were to determine the diagnostic findings, treatment efficacy, and follow-up characteristics of children with secondary osteoporosis. Methods: Patients diagnosed with secondary osteoporosis between January 2000 and January 2021 were included. The research was a cross-sectional and descriptive study. Study participants had to be under 18 years of age when the primary underlying disease was diagnosed and had received treatment for secondary osteoporosis. Patient data were collected from patient files. Statistical analysis was performed using Statistical Package for the Social Sciences, version 20.0 (IBM Corp, Armonk, NY, USA). Results: Sixty-one patients (28 female; 45.9%) were evaluated. The most common underlying primary diseases were inflammatory diseases (57.7%), neuromuscular diseases (26.2%), immunodeficiency (13.1%), acute lymphoblastic leukemia (8.2%), metabolic diseases (8.2%), solid organ transplantation (8.2%), bone marrow transplantation (6.6%) and epilepsy (6.6%). The mean +/- standard deviation chronological age when secondary osteoporosis was diagnosed was 11.89 +/- 4.88 years. Patients were evaluated for osteoporosis at a mean of 6.39 +/- 5.13 years after the onset of the underlying primary chronic diseases. Most (78.7%) had a history of one or more chronic drug use, including systemic steroids (59%), chemotherapeutics (23%), immunomodulatory drugs (19.7%), antiepileptic drugs (8.2%), inhaled steroids (4.9%), intravenous immunoglobulin (1.6%), and antituberculosis drugs 1.6%.Bone pain was detected in 49.2%. All patients had vertebral fractures before treatment. Bisphosphonate treatment was given to 45 (73.8%). There was a significant increase in mean bone mineral density (BMD) and bone mineral content six months after treatment (both p<0.001). There was a significant increase in BMD Z-score values for chronological and height age (both p<0.001). Overall mean BMD values increased by 31.15% with treatment. Following bisphosphonate treatment, there was a significant reduction in both fracture number and bone pain (p<0.01). Similar benefits from bisphosphonate treatment were evident in those who did or did not receive steroid treatment. Conclusion: Secondary osteoporosis is a condition that is influenced by many factors, such as the primary disease causing osteoporosis and chronic medication use, especially steroids. If left untreated, osteoporosis may lead to clinically important morbidity (bone pain, fractures, immobilization) and reduced linear growth of bone. When used to treat childhood secondary osteoporosis, bisphosphonates significantly improve BMD and reduced fracture risk.
- 2 July 2024
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 16 (4) , 466-474
Open AccessAssessment of the Admission and Follow-up Characteristics of Children Diagnosed with Secondary Osteoporosis
Objective: Secondary osteoporosis is a condition when the underlying disease or its treatment causes the bone mass to decrease and the bone structure to deteriorate, increasing the risk of fracture. The importance of diagnosis and treatment during childhood and adolescence is due to the long-term negative effects. In this study, our objectives were to determine the diagnostic findings, treatment efficacy, and follow-up characteristics of children with secondary osteoporosis. Methods: Patients diagnosed with secondary osteoporosis between January 2000 and January 2021 were included. The research was a cross-sectional and descriptive study. Study participants had to be under 18 years of age when the primary underlying disease was diagnosed and had received treatment for secondary osteoporosis. Patient data were collected from patient files. Statistical analysis was performed using Statistical Package for the Social Sciences, version 20.0 (IBM Corp, Armonk, NY, USA). Results: Sixty-one patients (28 female; 45.9%) were evaluated. The most common underlying primary diseases were inflammatory diseases (57.7%), neuromuscular diseases (26.2%), immunodeficiency (13.1%), acute lymphoblastic leukemia (8.2%), metabolic diseases (8.2%), solid organ transplantation (8.2%), bone marrow transplantation (6.6%) and epilepsy (6.6%). The mean +/- standard deviation chronological age when secondary osteoporosis was diagnosed was 11.89 +/- 4.88 years. Patients were evaluated for osteoporosis at a mean of 6.39 +/- 5.13 years after the onset of the underlying primary chronic diseases. Most (78.7%) had a history of one or more chronic drug use, including systemic steroids (59%), chemotherapeutics (23%), immunomodulatory drugs (19.7%), antiepileptic drugs (8.2%), inhaled steroids (4.9%), intravenous immunoglobulin (1.6%), and antituberculosis drugs 1.6%.Bone pain was detected in 49.2%. All patients had vertebral fractures before treatment. Bisphosphonate treatment was given to 45 (73.8%). There was a significant increase in mean bone mineral density (BMD) and bone mineral content six months after treatment (both p<0.001). There was a significant increase in BMD Z-score values for chronological and height age (both p<0.001). Overall mean BMD values increased by 31.15% with treatment. Following bisphosphonate treatment, there was a significant reduction in both fracture number and bone pain (p<0.01). Similar benefits from bisphosphonate treatment were evident in those who did or did not receive steroid treatment. Conclusion: Secondary osteoporosis is a condition that is influenced by many factors, such as the primary disease causing osteoporosis and chronic medication use, especially steroids. If left untreated, osteoporosis may lead to clinically important morbidity (bone pain, fractures, immobilization) and reduced linear growth of bone. When used to treat childhood secondary osteoporosis, bisphosphonates significantly improve BMD and reduced fracture risk.
- Open Access
- 23 August 2023
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 15 (3) , 230-237
Evaluation of Abnormal Uterine Bleeding in Adolescents: Single Center Experience
Abnormal uterine bleeding (AUB) is adolescent girls' most common gynecologic complaint. This study aimed to determine the diagnostic and management differences between those with/without heavy menstrual bleeding. We collected retrospective data such as follow-up, final control, and treatment regimen of adolescents aged 10-19 with the diagnosis of AUB. We excluded adolescents with known bleeding disorders at admission. We classified all subjects according to the level of anemia. Group 1 consisted of subjects with heavy bleeding (Hb10 g/dl) presented in Group 2. Admission and follow-up characteristics between the two groups were compared. In this study, we included 79 adolescent girls with a mean age was 14.3±1.8 years. 85% of all had a menstrual irregularity in the first two years after menarche. Anovulation was observed in 80%. 95% of group 1 had irregular bleeding in the two years (pMTHFR mutation. None had venous thromboembolism during at least six month-follow-up-period. This study showed that 85% of AUB had occurred in the first two years. We found the frequency of hematological disease (Factor 7 deficiency) 10.7%. The frequency of MTHFR mutation was 50%. We thought this did not increase the risk of bleeding/thrombosis. Its routine evaluation was not necessarily due to the similarity in population frequency.
- 23 August 2023
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 15 (3) , 230-237
Open AccessEvaluation of Abnormal Uterine Bleeding in Adolescents: Single Center Experience
Abnormal uterine bleeding (AUB) is adolescent girls' most common gynecologic complaint. This study aimed to determine the diagnostic and management differences between those with/without heavy menstrual bleeding. We collected retrospective data such as follow-up, final control, and treatment regimen of adolescents aged 10-19 with the diagnosis of AUB. We excluded adolescents with known bleeding disorders at admission. We classified all subjects according to the level of anemia. Group 1 consisted of subjects with heavy bleeding (Hb10 g/dl) presented in Group 2. Admission and follow-up characteristics between the two groups were compared. In this study, we included 79 adolescent girls with a mean age was 14.3±1.8 years. 85% of all had a menstrual irregularity in the first two years after menarche. Anovulation was observed in 80%. 95% of group 1 had irregular bleeding in the two years (pMTHFR mutation. None had venous thromboembolism during at least six month-follow-up-period. This study showed that 85% of AUB had occurred in the first two years. We found the frequency of hematological disease (Factor 7 deficiency) 10.7%. The frequency of MTHFR mutation was 50%. We thought this did not increase the risk of bleeding/thrombosis. Its routine evaluation was not necessarily due to the similarity in population frequency.
- Open Access
- 1 September 2022
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 7 (3) , 446-452
Obez Çocuklarda Uyku Kalitesi ve İşeme Fonksiyonunun Değerlendirilmesi
Amaç: Çocuklarda obezite ikincil hastalıklara yol açabilen önemli bir sağlık sorunudur. Bu hastalarda artan intraabdominal ve intravezikal basınç işeme fizyolojisinde değişikliklere yol açar. Ayrıca insülin ve glukoz metabolizma bozukluğu da alt üriner sistem fonksiyonlarını etkileyebilmektedir. Bununla birlikte obezitenin uyku bozuklukları ile ilişkisi de bilinmektedir.Materyal ve Metot: İşeme ve uyku bozukluklarını belirlemek için hazırlanan anket, yaşları 9 ile 18 arasında olan, 100 obez çocuk hasta ile benzer yaş grubundaki 100 normal kilolu sağlıklı bireye uygulandı.Bulgular: Hasta grubunun %17’sinde kontrol grubunun %2’sinde gündüz idrar kaçırma şikayeti varken, nokturnal enürezis hasta grubunun %25’inde, kontrol grubunun ise %2’sinde gözlendi. Hasta grubunda sağlıklı kontrollere göre aşırı aktif mesane sıklığı da daha fazla idi (sırasıyla %15 ve %5; p<0,05). Ayrıca hasta grubunun daha yüksek oranda gece huzursuz uyuduğu, horladığı ve gün içinde yorgun göründüğü ve yine bu grupta belirgin artmış davranış bozukluğu ve öğrenme güçlüğü olduğu belirlendi.Sonuç: Bu çalışma obez çocuklarda azalmış uyku kalitesi ve işeme bozukluğunun sağlıklı gruba göre yüksek prevalansını gösteren ilk çalışmadır. Obezitenin bir çok sistemi olumsuz etkilemesine bağlı olarak ortaya çıkan patolojiler çocukluk çağında da hastalığın bir sendrom olarak değerlendirilmesinin gerekliliğini ortaya koymaktadır. Bu hastalarda multidisipliner yaklaşım tedavi başarısını artıracaktır.
- 1 September 2022
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 7 (3) , 446-452
Open AccessObez Çocuklarda Uyku Kalitesi ve İşeme Fonksiyonunun Değerlendirilmesi
Amaç: Çocuklarda obezite ikincil hastalıklara yol açabilen önemli bir sağlık sorunudur. Bu hastalarda artan intraabdominal ve intravezikal basınç işeme fizyolojisinde değişikliklere yol açar. Ayrıca insülin ve glukoz metabolizma bozukluğu da alt üriner sistem fonksiyonlarını etkileyebilmektedir. Bununla birlikte obezitenin uyku bozuklukları ile ilişkisi de bilinmektedir.Materyal ve Metot: İşeme ve uyku bozukluklarını belirlemek için hazırlanan anket, yaşları 9 ile 18 arasında olan, 100 obez çocuk hasta ile benzer yaş grubundaki 100 normal kilolu sağlıklı bireye uygulandı.Bulgular: Hasta grubunun %17’sinde kontrol grubunun %2’sinde gündüz idrar kaçırma şikayeti varken, nokturnal enürezis hasta grubunun %25’inde, kontrol grubunun ise %2’sinde gözlendi. Hasta grubunda sağlıklı kontrollere göre aşırı aktif mesane sıklığı da daha fazla idi (sırasıyla %15 ve %5; p<0,05). Ayrıca hasta grubunun daha yüksek oranda gece huzursuz uyuduğu, horladığı ve gün içinde yorgun göründüğü ve yine bu grupta belirgin artmış davranış bozukluğu ve öğrenme güçlüğü olduğu belirlendi.Sonuç: Bu çalışma obez çocuklarda azalmış uyku kalitesi ve işeme bozukluğunun sağlıklı gruba göre yüksek prevalansını gösteren ilk çalışmadır. Obezitenin bir çok sistemi olumsuz etkilemesine bağlı olarak ortaya çıkan patolojiler çocukluk çağında da hastalığın bir sendrom olarak değerlendirilmesinin gerekliliğini ortaya koymaktadır. Bu hastalarda multidisipliner yaklaşım tedavi başarısını artıracaktır.
- 13 January 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (5) , e1924-e1931
Steroid Hormone Profiles and Molecular Diagnostic Tools in Pediatric Patients With non-CAH Primary Adrenal Insufficiency
Context There is a significant challenge of attributing specific diagnoses to patients with primary adrenal insufficiency of unknown etiology other than congenital adrenal hyperplasia (non-CAH PAI). Specific diagnoses per se may guide personalized treatment or may illuminate pathophysiology. Objective This work aimed to investigate the efficacy of steroid hormone profiles and high-throughput sequencing methods in establishing the etiology in non-CAH PAI of unknown origin. Methods Pediatric patients with non-CAH PAI whose etiology could not be established by clinical and biochemical characteristics were enrolled. Genetic analysis was performed using targeted-gene panel sequencing (TPS) and whole-exome sequencing (WES). Plasma adrenal steroids were quantified by liquid chromatography–mass spectrometry and compared to that of controls. This study comprised 18 pediatric endocrinology clinics with 41 patients (17 girls, median age: 3 mo, range: 0-8 y) with non-CAH PAI of unknown etiology. Results A genetic diagnosis was obtained in 29 (70.7%) patients by TPS. Further molecular diagnosis could not be achieved by WES. Compared to a healthy control group, patients showed lower steroid concentrations, most statistically significantly in cortisone, cortisol, and corticosterone (P < .0001, area under the receiver operating characteristic curve: .96, .88, and .87, respectively). Plasma cortisol of less than 4 ng/mL, cortisone of less than 11 ng/mL, and corticosterone of less than 0.11 ng/mL had a greater than 95% specificity to ensure the diagnosis of non-CAH PAI of unknown etiology. Conclusion Steroid hormone profiles are highly sensitive for the diagnosis of non-CAH PAI of unknown etiology, but they are unlikely to point to a specific molecular diagnosis. TPS is an optimal approach in the molecular diagnosis of these patients with high efficacy, whereas little additional benefit is expected from WES.
- 13 January 2022
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (5) , e1924-e1931
Steroid Hormone Profiles and Molecular Diagnostic Tools in Pediatric Patients With non-CAH Primary Adrenal Insufficiency
Context There is a significant challenge of attributing specific diagnoses to patients with primary adrenal insufficiency of unknown etiology other than congenital adrenal hyperplasia (non-CAH PAI). Specific diagnoses per se may guide personalized treatment or may illuminate pathophysiology. Objective This work aimed to investigate the efficacy of steroid hormone profiles and high-throughput sequencing methods in establishing the etiology in non-CAH PAI of unknown origin. Methods Pediatric patients with non-CAH PAI whose etiology could not be established by clinical and biochemical characteristics were enrolled. Genetic analysis was performed using targeted-gene panel sequencing (TPS) and whole-exome sequencing (WES). Plasma adrenal steroids were quantified by liquid chromatography–mass spectrometry and compared to that of controls. This study comprised 18 pediatric endocrinology clinics with 41 patients (17 girls, median age: 3 mo, range: 0-8 y) with non-CAH PAI of unknown etiology. Results A genetic diagnosis was obtained in 29 (70.7%) patients by TPS. Further molecular diagnosis could not be achieved by WES. Compared to a healthy control group, patients showed lower steroid concentrations, most statistically significantly in cortisone, cortisol, and corticosterone (P < .0001, area under the receiver operating characteristic curve: .96, .88, and .87, respectively). Plasma cortisol of less than 4 ng/mL, cortisone of less than 11 ng/mL, and corticosterone of less than 0.11 ng/mL had a greater than 95% specificity to ensure the diagnosis of non-CAH PAI of unknown etiology. Conclusion Steroid hormone profiles are highly sensitive for the diagnosis of non-CAH PAI of unknown etiology, but they are unlikely to point to a specific molecular diagnosis. TPS is an optimal approach in the molecular diagnosis of these patients with high efficacy, whereas little additional benefit is expected from WES.
- 18 October 2021
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 13 (3) , 601-605
Çocuklarda Yabancı Cisim Aspirasyonu; Düzce Üniversitesi Beş Yıllık Sonuçlar
Foreign body aspiration is defined as the aspiration of a foreign body into the tracheobronchial tree. As the result of inhalation of materials such as foods, toys, bones, seeds occur acute-onset upper respiratory airway obstruction. Foreign body aspiration is a preventable cause of mortality and morbidity especially in younger than three years old children. Cough, cyanosis and wheezing are the most symptoms and findings. Bronchoscopy is the best-known technique for diagnosis and treatment. In this study, foreign body aspiration causes, risk factors and morbidity rates were evaluated retrospectively in the five years period in patients who admitted to Duzce University Faculty of Medicine Hospital Paediatric Emergency Department between August 2014 and November 2019. Yabancı cisim aspirasyonu, solunum yoluna yabancı maddelerin teneffüsü sonucu oluşan asfiksi ve boğulma olarak tanımlanır. Yiyecekler, oyuncaklar, kemikler, tohumlar gibi materyallerin solunması sonucunda akut başlangıçlı üst solunum yolu tıkanıklığı oluşur. Yabancı cisim aspirasyonu, özellikle üç yaşından küçük çocuklarda önlenebilir bir mortalite ve morbidite nedenidir. Öksürük, siyanoz ve hırıltılı solunum en sık karşılaşılan belirti ve bulgudur. Bronkoskopi, tanı ve tedavi için en iyi bilinen tekniktir. Bu çalışmada Ağustos 2014 - Kasım 2019 tarihleri arasında Düzce Üniversitesi Tıp Fakültesi Hastanesi Çocuk Acil Servisi'ne başvuran hastalarda beş yıllık dönemde yabancı cisim aspirasyon nedenleri, risk faktörleri ve morbidite oranları geriye dönük olarak değerlendirildi.
- 18 October 2021
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 13 (3) , 601-605
Çocuklarda Yabancı Cisim Aspirasyonu; Düzce Üniversitesi Beş Yıllık Sonuçlar
Foreign body aspiration is defined as the aspiration of a foreign body into the tracheobronchial tree. As the result of inhalation of materials such as foods, toys, bones, seeds occur acute-onset upper respiratory airway obstruction. Foreign body aspiration is a preventable cause of mortality and morbidity especially in younger than three years old children. Cough, cyanosis and wheezing are the most symptoms and findings. Bronchoscopy is the best-known technique for diagnosis and treatment. In this study, foreign body aspiration causes, risk factors and morbidity rates were evaluated retrospectively in the five years period in patients who admitted to Duzce University Faculty of Medicine Hospital Paediatric Emergency Department between August 2014 and November 2019. Yabancı cisim aspirasyonu, solunum yoluna yabancı maddelerin teneffüsü sonucu oluşan asfiksi ve boğulma olarak tanımlanır. Yiyecekler, oyuncaklar, kemikler, tohumlar gibi materyallerin solunması sonucunda akut başlangıçlı üst solunum yolu tıkanıklığı oluşur. Yabancı cisim aspirasyonu, özellikle üç yaşından küçük çocuklarda önlenebilir bir mortalite ve morbidite nedenidir. Öksürük, siyanoz ve hırıltılı solunum en sık karşılaşılan belirti ve bulgudur. Bronkoskopi, tanı ve tedavi için en iyi bilinen tekniktir. Bu çalışmada Ağustos 2014 - Kasım 2019 tarihleri arasında Düzce Üniversitesi Tıp Fakültesi Hastanesi Çocuk Acil Servisi'ne başvuran hastalarda beş yıllık dönemde yabancı cisim aspirasyon nedenleri, risk faktörleri ve morbidite oranları geriye dönük olarak değerlendirildi.
- Open Access
- 7 January 2021
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 11 (2) , 195-199
Adolesan Çocuklarda Hepatit B Belirteçlerinin İncelenmesi-Düzce Üniversitesi Hastanesi 5 Yıllık Sonuçlar
Amaç: Hepatit B virüsü (HBV), akut ve kronik karaciğer hastalığının ve bunlara bağlı morbidite ve mortalitenin başlıca nedenidir. Ülkemizde 1998 yılında Hepatit B aşısı rutin aşı takvimine alındı. Bu çalışmada, ülkemizde Hepatit B aşısı uygulanmaya başlandıktan sonra doğan çocuklardaki Hepatit B belirteçlerinin değerlendirilmesini amaçladık. Gereç ve Yöntemler: Düzce Üniversitesi Tıp Fakültesi Çocuk Polikliniklerine başvurup HBV seroloji testleri yapılan, rutin aşı takviminde aksama olmayan ve yaşları 10-19 arasında olan 310 çocuğun Hepatit B belirteçleri değerlendirildi. Çocukların tam aşılı sayılabilmeleri için 1999 ve sonrası doğumlu olanlar çalışmaya dahil edildi. Aynı hastanın farklı zamanlarda yapılan değerlendirmeleri çalışma dışı bırakıldı. Bulgular: Çalışmaya 166 (%53,5) erkek ve 144 (%46,5) kız toplam 310 çocuk alındı. Çocukların 192’sinde anti-HBs pozitif (%61,9), 118’inde (%38,1) negatif saptandı. Cinsiyetler açısından anti-HBs ve HBsAg pozitifliği karşılaştırıldığında anlamlı fark bulunmadı. Sonuç: Hepatit B aşısı sonrası bireylerin seropozitiflik durumları üzerine günümüzde fazla araştırma yapılmıyor olsa da çalışmamızda saptanan anti-HBs pozitiflik oranları; geniş bir popülasyonda yeni bir çalışma planlanarak aşılama sonrası anti-HBs düzeyinin değerlendirilmesinin tekrar gündeme gelmesini, belki de kişiden kaynaklanan sigara içme, fazla kilo problemi veya aşıların uygulanması yönünden kaynaklanan aşı transportu, saklama ve uygulama problemleri gibi sorunların ortaya çıkmasını sağlayarak, toplumda saptanan pozitif anti-HBs yüzdesinin istenilen düzeye gelmesini sağlayacaktır.
- 7 January 2021
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
- Vol. 11 (2) , 195-199
Open AccessAdolesan Çocuklarda Hepatit B Belirteçlerinin İncelenmesi-Düzce Üniversitesi Hastanesi 5 Yıllık Sonuçlar
Amaç: Hepatit B virüsü (HBV), akut ve kronik karaciğer hastalığının ve bunlara bağlı morbidite ve mortalitenin başlıca nedenidir. Ülkemizde 1998 yılında Hepatit B aşısı rutin aşı takvimine alındı. Bu çalışmada, ülkemizde Hepatit B aşısı uygulanmaya başlandıktan sonra doğan çocuklardaki Hepatit B belirteçlerinin değerlendirilmesini amaçladık. Gereç ve Yöntemler: Düzce Üniversitesi Tıp Fakültesi Çocuk Polikliniklerine başvurup HBV seroloji testleri yapılan, rutin aşı takviminde aksama olmayan ve yaşları 10-19 arasında olan 310 çocuğun Hepatit B belirteçleri değerlendirildi. Çocukların tam aşılı sayılabilmeleri için 1999 ve sonrası doğumlu olanlar çalışmaya dahil edildi. Aynı hastanın farklı zamanlarda yapılan değerlendirmeleri çalışma dışı bırakıldı. Bulgular: Çalışmaya 166 (%53,5) erkek ve 144 (%46,5) kız toplam 310 çocuk alındı. Çocukların 192’sinde anti-HBs pozitif (%61,9), 118’inde (%38,1) negatif saptandı. Cinsiyetler açısından anti-HBs ve HBsAg pozitifliği karşılaştırıldığında anlamlı fark bulunmadı. Sonuç: Hepatit B aşısı sonrası bireylerin seropozitiflik durumları üzerine günümüzde fazla araştırma yapılmıyor olsa da çalışmamızda saptanan anti-HBs pozitiflik oranları; geniş bir popülasyonda yeni bir çalışma planlanarak aşılama sonrası anti-HBs düzeyinin değerlendirilmesinin tekrar gündeme gelmesini, belki de kişiden kaynaklanan sigara içme, fazla kilo problemi veya aşıların uygulanması yönünden kaynaklanan aşı transportu, saklama ve uygulama problemleri gibi sorunların ortaya çıkmasını sağlayarak, toplumda saptanan pozitif anti-HBs yüzdesinin istenilen düzeye gelmesini sağlayacaktır.
- Open Access
- 30 December 2020
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 22 (3) , 226-229
Kadın Cinsiyet Disforisinin Nadir Bir Nedeni: Düşük Yüzdeli Turner Mozaisizmli Üç Olgu Raporu
Gender dysphoria is a condition caused by a mismatch between the gender assigned at birth and gender identity. Gender development disorders include situations where congenital chromosomal, gonadal, or anatomically gender-related physical features are atypical. In the studies conducted mostly by karyotype analysis, it is reported that the rate of chromosomal abnormality is very low in people with gender dysphoria. In Turner mosaicism, gender dysphoria is not a common finding. In this case series, we examined the phenotype and genotype characteristics of the three cases identified as Turner mosaicism, who applied with gender dysphoria. The patients’ complaints were feeling like a male, negative thoughts about being a female, being uncomfortable with feminine body image, wanting to have a male body. None of our 3 cases had Turner stigmata however their chromosomal or FISH analyses showed that one of them was 45,X/46 XX/47,XXX and two of them were 45 X/46 XX karyotype.
- 30 December 2020
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 22 (3) , 226-229
Open AccessKadın Cinsiyet Disforisinin Nadir Bir Nedeni: Düşük Yüzdeli Turner Mozaisizmli Üç Olgu Raporu
Gender dysphoria is a condition caused by a mismatch between the gender assigned at birth and gender identity. Gender development disorders include situations where congenital chromosomal, gonadal, or anatomically gender-related physical features are atypical. In the studies conducted mostly by karyotype analysis, it is reported that the rate of chromosomal abnormality is very low in people with gender dysphoria. In Turner mosaicism, gender dysphoria is not a common finding. In this case series, we examined the phenotype and genotype characteristics of the three cases identified as Turner mosaicism, who applied with gender dysphoria. The patients’ complaints were feeling like a male, negative thoughts about being a female, being uncomfortable with feminine body image, wanting to have a male body. None of our 3 cases had Turner stigmata however their chromosomal or FISH analyses showed that one of them was 45,X/46 XX/47,XXX and two of them were 45 X/46 XX karyotype.